A股異動丨愛康科技(002610.SZ)漲逾8% 擬推第一期員工持股計劃
格隆匯1月27日丨愛康科技(002610.SZ)漲逾8%,報3.89港元,總市值174億元。愛康科技發佈第一期員工持股計劃(草案),本次員工持股計劃擬設立時的資金總額不超過人民幣4284.74萬元,對應的股份數量不超過1983.676萬股,佔公司當前總股本的0.44%。本員工持股計劃將在股東大會審議通過後6個月內,通過非交易過户等法律法規允許的方式獲得公司回購專用證券賬户所持有的公司股票,受讓價格為2.16元/股。擬參與本員工持股計劃的員工總人數不超過9人,其中董事、監事、高級管理人員2人。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.